Capital Health
Adam Lenkowsky is the general manager and head of U.S. Cardiovascular, Immunology and Oncology at Bristol Myers Squibb (BMS). In this role, he heads a business unit that in 2018 contributed 56% of the company’s $22.6 billion in revenue. He leads an organization of more than 2,500 employees that deliver transformational medicines such as Eliquis, Opdivo, Yervoy and Orencia. He is passionate about cultivating a culture that prioritizes its people, performance, customers and above all else - patients.
Adam’s full biopharma career extends more than 20 years across commercial, market access, sales, and operations. He has held a number of commercial leadership positions at BMS.
This person is not in the org chart
This person is not in any offices
Capital Health
Capital Health is the region’s leader in providing progressive, quality patient care with significant investments in our exceptional physicians, nurses and staff, as well as advanced technology. Comprised of two hospitals (their Regional Medical Center in Trenton and Capital Health Medical Center – Hopewell), their Hamilton outpatient facility, and various primary and specialty care practices across the region, Capital Health is a dynamic healthcare resource accredited by The Joint Commission and a three-time Magnet-designated health system for nursing excellence.